1. Home
  2. IPHA vs BHR Comparison

IPHA vs BHR Comparison

Compare IPHA & BHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

HOLD

Current Price

$1.71

Market Cap

174.2M

Sector

Health Care

ML Signal

HOLD

BHR

Braemar Hotels & Resorts Inc.

HOLD

Current Price

$2.88

Market Cap

185.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPHA
BHR
Founded
1999
2013
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
174.2M
185.6M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
IPHA
BHR
Price
$1.71
$2.88
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
26.6K
728.0K
Earning Date
09-17-2025
11-04-2025
Dividend Yield
N/A
6.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,839,695.00
$710,399,000.00
Revenue This Year
$22.29
N/A
Revenue Next Year
$43.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$1.80
52 Week High
$2.63
$3.34

Technical Indicators

Market Signals
Indicator
IPHA
BHR
Relative Strength Index (RSI) 36.12 58.60
Support Level $1.64 $2.79
Resistance Level $1.81 $2.95
Average True Range (ATR) 0.08 0.11
MACD -0.01 0.02
Stochastic Oscillator 18.75 83.95

Price Performance

Historical Comparison
IPHA
BHR

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

About BHR Braemar Hotels & Resorts Inc.

Braemar Hotels & Resorts Inc is a real estate investment trust company that invests in high revenue per available room, or RevPAR, luxury, upper-upscale and upscale hotels in gateway and resort locations. The firm operates in various U.S. states such as California, Texas, Washington, Philadelphia, Florida, and Illinois as well as Washington, D.C. and St. Thomas, U.S. Virgin Islands. The company operates through its direct hotel investment segment of the hotel lodging industry. Its revenue streams include rooms, food and beverage, and other. The firm's hotels operate under various brands, such as Marriott, Hilton, Courtyard, and, among others.

Share on Social Networks: